ctrl K

Price Alert

OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · Real-Time Price · USD

2.30

-0.11 (-4.56%)

At close: Aug 19, 2025, 1:54 PM

OKYO Pharma Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.56M	826.85K	4.05M	2.7M	6.89M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a
Receivables	1.89M	580.94K	n/a	n/a	4.5K
Inventory	n/a	n/a	n/a	-1.49K	34.00
Other Current Assets	n/a	n/a	n/a	n/a	71.79K
Total Current Assets	3.68M	1.54M	5.2M	4.3M	6.99M
Property-Plant & Equipment	2.04K	3.35K	7.22K	5.22K	104.64K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.04K	3.35K	7.22K	5.22K	104.64K
Total Assets	3.68M	1.54M	5.2M	4.3M	7.09M
Account Payables	7.9M	6.13M	1.02M	517.67K	210.99K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	1.8M	n/a	n/a
Other Current Liabilities	n/a	n/a	1.71M	323.06K	1.46M
Total Current Liabilities	9.23M	7.42M	7.26M	1.35M	1.71M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	64.61K
Total Liabilities	9.23M	7.42M	7.26M	1.35M	1.77M
Total Debt	n/a	n/a	2.22M	n/a	98.76K
Common Stock	146.72M	n/a	131.39M	123.98M	111.63M
Retained Earnings	-143.02M	-142.52M	-125.7M	-112.43M	-106M
Comprehensive Income	-11.47M	-11.31M	-11.45M	-11.01M	12.82M
Shareholders Equity	-5.55M	-5.88M	-2.05M	2.95M	5.32M
Total Investments	n/a	n/a	n/a	n/a	n/a